Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20
What Market Value Is The Biologic Imaging Reagents Industry Expected To Reach By 2029, Starting From 2025 Levels?
The biologic imaging reagents market has experienced robust expansion in recent years. This market is projected to expand from $18.41 billion in 2024 to $20.1 billion in 2025, at a compound annual growth rate (CAGR) of 9.1%. Historically, this growth has been driven by factors such as the increasing prevalence of chronic diseases, augmented investments in research and development, a shift towards personalized medicine, a focus on early disease detection, an increasing geriatric population, and strengthened collaborations in biomedical research.
The market for biologic imaging reagents is projected to experience substantial expansion in the coming years. This market is anticipated to reach a valuation of $27.49 billion by 2029, exhibiting a compound annual growth rate (CAGR) of 8.1%. Several factors contribute to this projected growth, including the expanding utility in drug development, an increasing need for molecular imaging, a greater emphasis on non-invasive diagnostic approaches, the worldwide rise in cancer diagnoses, and the evolving trend toward value-based healthcare. Key developments expected during this period involve an increased call for contrast-enhanced imaging agents, the creation of targeted molecular imaging agents, the incorporation of nanoparticles in imaging techniques, the appearance of fluorescent probes for in vivo imaging, and the integration of artificial intelligence into image analysis processes.
Unlock Your Free Sample Report for Exclusive Market Data:
https://www.thebusinessresearchcompany.com/sample.aspx?id=13389&type=smp
Which Factors And Drivers Are Influencing The Biologic Imaging Reagents Market In 2025?
The escalating prevalence of chronic diseases is poised to drive the growth of the biologic imaging reagents market moving forward. Chronic diseases are defined as conditions lasting a year or more, demanding continuous medical attention, and potentially worsening over time. These conditions necessitate biologic imaging reagents for diagnosis and detection through the visualization of organs and affected structures. For example, in 2022, the American Cancer Society, a US-based voluntary organization, estimated 1.9 million new cancer cases and 609,360 cancer deaths in the United States. Furthermore, in January 2023, the National Library of Medicine, a US-based agency, indicated that the number of individuals in the US aged 50 and older with at least one chronic condition is projected to increase by 99.5%, from 71.522 million to 142.66 million by 2050. This rise in chronic disease prevalence is a key factor propelling the expansion of the biologic imaging reagents market.
What Are The Major Segment Categories Driving The Biologic Imaging Reagents Market Growth?
The biologic imaging reagentsmarket covered in this report is segmented –
1) By Product: Contrast Reagents; Optical Imaging Reagents; Radiopharmaceuticals
2) By Modality: Magnetic Resonance Imaging (MRI); Ultrasound; X-Ray And Computerized Tomography (CT); Nuclear; Optical Imaging; Other Modalities
3) By Application: In Vitro; In Vivo
4) By End User: Diagnostic Laboratories; Imaging Centers; Life Science Companies; Research And Academic Institutes; Other End Users
Subsegments:
1) By Contrast Reagents: X-ray Contrast Agents; MRI Contrast Agents; Ultrasound Contrast Agents
2) By Optical Imaging Reagents: Fluorescent Dyes; Bioluminescent Reagents; Quantum Dots
3) By Radiopharmaceuticals: Diagnostic Radiopharmaceuticals; Therapeutic Radiopharmaceuticals
Which Trends Are Impacting The Biologic Imaging Reagents Market?
Leading companies in the biologic imaging reagents market are primarily focused on developing innovative reagents, such as novel dye technology, to equip researchers and clinicians with advanced tools for visualizing and enhancing the sensitivity and specificity of biologic imaging. Novel dye technology involves the creation of new dyes for a range of applications, including biological imaging. For example, in April 2022, Becton, Dickinson, and Company, a US-based medical device firm, launched its BD Horizon RealYellow 586 Reagents and RealBlue Reagents. This new family of reagents enables researchers to obtain higher data resolution and extract more profound insights from samples compared to standard fluorochromes. This capability stems from the integration of revolutionary dye technology along with artificial intelligence (AI) supervision. The AI played a crucial role by analyzing existing data on the excitation and emission profiles of commercially available fluorochromes to identify optimal laser line placements for the development of these novel dyes.
Who Are The Major Companies Operating In The Biologic Imaging Reagents Market?
Major companies operating in the biologic imaging reagents market report are Cardinal Health Inc., Johnson And Johnson Services Inc., Bayer Healthcare AG, Thermo Fisher Scientific Inc., Siemens Healthcare GmbH, Dickinson and Company (BD), Koninklijke Philips N.V., GE HealthCare Technologies Inc., Stryker Corporation, FluoroPharma Medical Inc., Lonza Group AG, Illumina Inc., PerkinElmer Inc., Becton, Dickinson and Company, Bio-Rad Laboratories Inc., Bracco Diagnostics Inc., Leica Microsystems GmbH, Lantheus Medical Imaging Inc., Guerbet SA, Miltenyi Biotec B.V. and Co. KG, Promega Corporation, Abcam plc., Luminex Corporation, MILabs, LI-COR Biosciences, FUJIFILM VisualSonics Inc., Advanced Proteome Therapeutics Incorporated, BIOPRO Baden-Württemberg GmbH, ABX Advanced Biochemical Compounds GmbH
Download The Full Report For Exclusive Market Findings:
https://www.thebusinessresearchcompany.com/report/biologic-imaging-reagents-global-market-report
What Are The Regional Market Dynamics Impacting The Biologic Imaging Reagents Industry?
North America was the largest region in the biologic imaging reagents market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the biologic imaging reagents market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Customized Version Of The Biologic Imaging Reagents Market Report:
https://www.thebusinessresearchcompany.com/customise?id=13389&type=smp
Browse Through More Reports Similar to the Global Biologic Imaging Reagents Market 2025, By The Business Research Company
Bioabsorbable Stents Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/bioabsorbable-stents-global-market-report
Bioinformatics Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/bioinformatics-global-market-report
Biophotonics Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/biophotonics-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model